v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Aug. 31, 2026
Aug. 31, 2025
Cash provided by operating activities:    
Net income (loss) $ 40,394 $ (759,361)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 26,397 26,944
Amortization of financing costs 811 764
Non-cash operating lease expense 6,602 4,336
Provision for credit losses 1,430 342
Non-cash share-based compensation 11,580 9,668
Asset impairment charges 0 740,779
Gain on sale of distribution facility  (54,854) 0
Gain on the sale or disposal of property and equipment (32) (75)
Deferred income taxes and tax credits 4,677 (25,770)
Changes in operating capital, net of effects of acquisition of business:    
Receivables 31,221 77,353
Inventory (24,513) (76,278)
Prepaid expenses and other current assets (13,179) (8,006)
Other assets and liabilities, net 2,368 (1,756)
Accounts payable 22,926 11,723
Accrued expenses and other current liabilities 7,987 26,378
Accrued income taxes (7,364) 20,827
Net cash provided by operating activities 56,451 47,868
Cash provided (used) by investing activities:    
Capital and intangible asset expenditures (18,111) (24,832)
Net proceeds from business acquired 0 3,880
Payments for purchases of U.S. Treasury Bills (1,456) (1,387)
Proceeds from maturities of U.S. Treasury Bills 1,321 1,275
Proceeds from sale of distribution facility 78,160 0
Proceeds from the sale of property and equipment 32 89
Proceeds from promissory note 328 0
Net cash provided (used) by investing activities 60,274 (20,975)
Cash used by financing activities:    
Proceeds from revolving loans 456,030 317,200
Repayment of revolving loans (552,530) (583,400)
Proceeds from term loans 0 250,000
Repayment of long-term debt (12,500) (7,031)
Payment of financing costs 0 (434)
Payment for contingent consideration (4,100) 0
Proceeds from share issuances under share-based compensation plans 1,334 1,757
Payments for repurchases of common stock (1,262) (1,482)
Net cash used by financing activities (113,028) (23,390)
Net increase in cash and cash equivalents 3,697 3,503
Cash and cash equivalents, beginning balance 18,886 18,867
Cash and cash equivalents, ending balance 22,583 22,370
Supplemental non-cash investing activity:    
Capital expenditures included in accounts payable and accrued expenses $ 6,939 $ 7,953